Study to Compare the Efficacy and Safety of Two Non-Preserved Artificial Tears for the Treatment of Dry Eye Signs and Symptoms

Allergan

Status and phase

Completed

Phase 4

Conditions

Dry Eye Syndromes

Treatments

Drug: sodium hyaluronate 0.18%

Drug: carboxymethylcellulose 0.5% +glycerin 0.9%

Study type

Interventional

Funder types

Industry

Identifiers

NCT00938704

MA-OPT-09-002

Details and patient eligibility

About

To compare the efficacy and safety of two non-preserved artificial tears, (carboxymethylcellulose 0.5%, + glycerin 0.9% vs. sodium hyaluronate 0.18%) eye drops for the treatment of the signs and symptoms of dry eye disease.

Enrollment

71 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Current use of an artificial tear product at least 2 times per day (e.g. for relief of dry eye symptoms of dryness).
Be likely to complete the entire course of study and to comply with appropriate instructions

Exclusion criteria

Have undergone refractive surgery (e.g., cataract surgery, PRK, LASIK, or any surgery involving a limbal or corneal incision) within the last 12 months.
Have uncontrolled systemic disease
Are currently using, or have used within 14 days of study enrollment, any ocular medications other than artificial tears
Have anticipated contact lens wear during the study
Have an active ocular infection